v3.25.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net sales $ 936 $ 984 $ 1,815 $ 1,937
Cost of products sold 446 473 859 920
Gross profit 490 511 956 1,017
Selling, general, and administrative expenses 342 399 700 814
Research and development expenses 37 41 73 83
Goodwill and intangible asset impairments 235 0 235 6
Restructuring and other costs 4 21 13 22
Operating (loss) income (128) 50 (65) 92
Other income and expenses:        
Interest expense, net 24 17 43 35
Other expense (income), net 1 (1) 1 (8)
(Loss) income before income taxes (153) 34 (109) 65
(Benefit) provision for income taxes (109) 38 (84) 52
Net (loss) income (44) (4) (25) 13
Less: Net income (loss) attributable to noncontrolling interest 1 0 0 (1)
Net (loss) income attributable to Dentsply Sirona $ (45) $ (4) $ (25) $ 14
(Loss) earnings per common share attributable to Dentsply Sirona:        
Basic (in dollars per share) $ (0.22) $ (0.02) $ (0.13) $ 0.07
Diluted (in dollars per share) $ (0.22) $ (0.02) $ (0.13) $ 0.07
Weighted average common shares outstanding:        
Basic (in shares) 199.3 205.6 199.2 206.5
Diluted (in shares) 199.3 205.6 199.2 207.3